The late-onset phenotype represents the most prevalent form of ornithine transcarbamylase (OTC) deficiency and is characterized by marked clinical heterogeneity, with disease onset ranging from early infancy to adulthood. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.